Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Review of phase II trials of Taxol (paclitaxel) in patients with advanced ovarian cancerA I EinzigJournal of the National Cancer Institute. Monographs|January 1, 1993
Taxol in malignant melanomaP H Wiernik, A I EinzigCancer Investigation|January 1, 1991
Phase II trial of taxol in patients with metastatic renal cell carcinomaA I Einzig, E Gorowski, J Sasloff, et al.Investigational New Drugs|January 1, 1995
Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT). The Eastern Cooperative Oncology group (ECOG) resultsA I Einzig, S Lipsitz, P H Wiernik, et al.American Journal of Clinical Oncology|February 20, 1999
Non-Hodgkin lymphoma in acquired immunodeficiency syndrome manifesting as bilateral hypopyonN A Jan, A I Einzig, M J Suhrland, et al.The Journal of Infectious Diseases|January 1, 1991
Instillation of vancomycin into a cerebrospinal fluid reservoir to clear infection: pharmacokinetic considerationsB E Hirsch, M Amodio, A I Einzig, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinomaA I Einzig, P H Wiernik, J Sasloff, et al.Medical Oncology (Northwood, London, England)|June 1, 1996
Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapyA I Einzig, L M Schuchter, A Recio, et al.The Cancer Journal From Scientific American|August 5, 1998
Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's diseaseP H Wiernik, J P Dutcher, A I Einzig, et al.Pageof 2